The EuroEyes International Medical Advisory Board (IMAB) annually brings together the world’s leading eye specialists, including practicing surgeons and academics, to discuss the latest scientific developments in refractive and cataract surgery.
The EuroEyes IMAB comprises a group of internationally renowned ophthalmologists and opinion leaders in the field of refractive surgery. The board advises the EuroEyes senior management team on the latest scientific findings and their derivations for concrete initiatives and further developments. It advises the company on breakthrough treatment developments, new technologies and general trends in cataract and refractive surgery to further strengthen EuroEyes’ leading position in the correction of refractive errors.
This enables EuroEyes to offer patients around the world the optimal medical technologies for them. The EuroEyes IMAB is unique in the world, as hardly any other listed vision correction clinic group has established such a medical advisory board within the company.
In addition to Dr. Jørgensen, Prof. Dr. Knorz, Prof. Dr. Neuhann and PD Dr. Lerche, the EuroEyes IMAB also includes Prof. Dr. Dick, Prof. Yao Ke, Professor Gerd U. Auffarth and Professor Dan Reinstein, who are also internationally renowned ophthalmologists and specialists in the field of vision correction.
In 2022, EuroEyes has succeeded in attracting two of the brightest minds in ophthalmology to IMAB: Professor Gerd U. Auffarth, Head of Ophthalmology at the University of Heidelberg Eye Clinic and Professor Dan Reinstein, Founder and Medical Director of the London Vision Clinic.
Jørn Slot Jørgensen, MD, Founder, Director and CEO of the EuroEyes group of clinics commented, “We are pleased to welcome Professor Gerd U. Auffarth and Professor Dan Reinstein to our International Medical Advisory Board. One of our commitments to our stakeholders is to drive innovation in vision correction that can bring them exceptional value. The appointment of two of the world’s best in their respective fields allows EuroEyes to draw on their experience and expertise, which will help take our service to the next level and deliver positive outcomes for our patients, surgeons and shareholders.”
THE MEMBERS
As key opinion leaders on the “EuroEyes International Medical Advisory Board”, Prof. Dr. Neuhann and Prof. Dr. Knorz are graduates of internationally renowned medical schools and have contributed to more than 100 scientific publications in the field of vision correction.
Prof. Yao Ke is the director of SAHZU Eye Center, Zhejiang University and has contributed to more than 300 scientific publications as the president of Chinese Society of Ophthalmology.
Prof. Dr. Dick enjoys an outstanding reputation in the international community of ophthalmologists as one of the pioneers in the field of blade-free cataract surgery.
Professor Dan Reinstein is a pioneer in the field of therapeutic refractive surgery and editor of the Journal of Refractive Surgery section. He is the developer of the laser blended vision, PRESBYOND® procedure. Professor Dan Reinstein is a board-certified ophthalmic surgeon in the United Kingdom, the United States and Canada and holds professorships in the United Kingdom, at Columbia University in New York and at Sorbonne University in Paris.
Professor Gerd U. Auffarth is one of the world’s leading experts on intraocular lenses and a member of the European Board of Ophthalmology (FEBO). He will act as a consultant to EuroEyes in developing new surgical techniques and improving patient care.
Professor Christopher Liu is a highly respected Consultant Ophthalmic Surgeon at the Sussex Eye Hospital in Brighton, UK, with a special interest in cornea and anterior segment. He has held numerous prestigious academic appointments.
Board members work closely together to advance medical education among EuroEyes employees, promote innovation in technology and raise the standard of quality and service in refractive surgery.